The Blog
-
Sep 12, 2024
ARV-471: A Promising Oral SERD Transforming the Treatment of ER+ Breast Cancer
READ MORE -
Sep 11, 2024
Targeting Phagocytosis Checkpoints: A New Frontier in Cancer Immunotherapy
READ MORE -
Sep 06, 2024
ARV-766: A Promising PROTAC for Overcoming Resistance in Advanced Prostate Cancer
READ MORE -
Sep 06, 2024
Advances in Genitourinary Tissue Engineering: Insights from Cutting-Edge Research
READ MORE -
Aug 29, 2024
Avatrombopag: Advancing Thrombocytopenia Management with Enhanced Safety and Broader Applications
READ MORE -
Aug 27, 2024
Apixaban: A Breakthrough in Anticoagulation Therapy and Stroke Prevention
READ MORE -
Aug 26, 2024
Neratinib: A Crucial Component of Targeted Treatment for CNS Metastases and HER2-Positive Breast Cancer
READ MORE -
Aug 22, 2024
Exploring the Potential of Quinolones in Treating Genitourinary Cancers
READ MORE -
Aug 21, 2024
Enhancing ADPKD Treatment: The Potential of Trichlormethiazide in Improving Tolvaptan Tolerability
READ MORE